Gene-panel sequencing and the prediction of breast-cancer risk
- PMID: 26014596
- PMCID: PMC4610139
- DOI: 10.1056/NEJMsr1501341
Gene-panel sequencing and the prediction of breast-cancer risk
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4610139/bin/nihms711772f1.gif)
Comment in
-
ClinGen and Genetic Testing.N Engl J Med. 2015 Oct;373(14):1378. doi: 10.1056/NEJMc1508700. N Engl J Med. 2015. PMID: 26422736 No abstract available.
-
ClinGen and Genetic Testing.N Engl J Med. 2015 Oct;373(14):1376-7. doi: 10.1056/NEJMc1508700. N Engl J Med. 2015. PMID: 26422737 No abstract available.
-
ClinGen and Genetic Testing.N Engl J Med. 2015 Oct;373(14):1377. doi: 10.1056/NEJMc1508700. N Engl J Med. 2015. PMID: 26422738 No abstract available.
-
ClinGen and Genetic Testing.N Engl J Med. 2015 Oct;373(14):1377. doi: 10.1056/NEJMc1508700. N Engl J Med. 2015. PMID: 26422739 No abstract available.
-
ClinGen and Genetic Testing.N Engl J Med. 2015 Oct;373(14):1377-8. doi: 10.1056/NEJMc1508700. N Engl J Med. 2015. PMID: 26422740 No abstract available.
Similar articles
-
Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history.Breast Cancer Res Treat. 2014 Apr;144(3):635-42. doi: 10.1007/s10549-014-2894-x. Epub 2014 Mar 1. Breast Cancer Res Treat. 2014. PMID: 24578176
-
US panel rejects routine use of BRCA cancer screening in women.BMJ. 2013 Apr 4;346:f2160. doi: 10.1136/bmj.f2160. BMJ. 2013. PMID: 23558348 No abstract available.
-
Curating the way to better determinants of genetic risk.N Engl J Med. 2015 Jun 4;372(23):2227-8. doi: 10.1056/NEJMe1506276. Epub 2015 May 27. N Engl J Med. 2015. PMID: 26014597 No abstract available.
-
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243. J Med Genet. 2005. PMID: 15744030 Free PMC article. Review. No abstract available.
-
"Decoding hereditary breast cancer" benefits and questions from multigene panel testing.Breast. 2019 Jun;45:29-35. doi: 10.1016/j.breast.2019.01.002. Epub 2019 Jan 8. Breast. 2019. PMID: 30822622 Review.
Cited by
-
Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancer.J Transl Med. 2024 Aug 5;22(1):726. doi: 10.1186/s12967-024-05509-9. J Transl Med. 2024. PMID: 39103897 Free PMC article.
-
Unraveling noncoding DNA variants and epimutations: a paradigm shift in hereditary cancer research.Future Oncol. 2024;20(18):1289-1298. doi: 10.2217/fon-2023-0665. Epub 2024 May 9. Future Oncol. 2024. PMID: 38722139 Review.
-
Uncovering hidden genetic risk factors for breast and ovarian cancers in BRCA-negative women: a machine learning approach in the Saudi population.PeerJ Comput Sci. 2024 Apr 19;10:e1942. doi: 10.7717/peerj-cs.1942. eCollection 2024. PeerJ Comput Sci. 2024. PMID: 38660159 Free PMC article.
-
Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status.Breast Cancer Res. 2024 Mar 21;26(1):51. doi: 10.1186/s13058-024-01809-6. Breast Cancer Res. 2024. PMID: 38515142 Free PMC article.
-
The Impact of microRNA SNPs on Breast Cancer: Potential Biomarkers for Disease Detection.Mol Biotechnol. 2024 Mar 21. doi: 10.1007/s12033-024-01113-w. Online ahead of print. Mol Biotechnol. 2024. PMID: 38512426 Review.
References
-
- Assoc. for Molecular Pathology v. Myriad Genetics, Inc. 569 U.S. 2013 ( https://supreme.justia.com/cases/federal/us/569/12-398).
-
- Grady D, Pollack A. Finding risks, not answers, in gene tests. New York Times; 2014. Sep 22, ( http://www.nytimes.com/2014/09/23/health/finding-risks-not-answers-in-ge...).
-
- Haddow JE, Palomaki GE. ACCE: a model process for evaluating data on emerging genetic tests. In: Khoury MJ, Little J, Burke W, editors. Human genome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease. Oxford, United Kingdom: Oxford University Press; 2003. pp. 217–233.
-
- National Institute for Health and Care Excellence. Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. London: National Collaborating Center for Cancer; 2013. ( http://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq#sectio...). - PubMed
-
- Hayes DF, Allen J, Compton C, et al. Breaking a vicious cycle. Sci Transl Med. 2013;5 cm6. - PubMed
Publication types
MeSH terms
Grants and funding
- A11174/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
- R01 CA176785/CA/NCI NIH HHS/United States
- 11174/CRUK_/Cancer Research UK/United Kingdom
- U01 CA116167/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- R01 CA192393/CA/NCI NIH HHS/United States
- CA176785/CA/NCI NIH HHS/United States
- R01 CA116167/CA/NCI NIH HHS/United States
- CA192393/CA/NCI NIH HHS/United States
- CA116167,/CA/NCI NIH HHS/United States
- RP-PG-0707-10031/DH_/Department of Health/United Kingdom
- 15106/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical